Rhabdomyolysis: pathogenesis, diagnosis, and treatment.
暂无分享,去创建一个
[1] J. Sprung,et al. Anesthesia and Duchenne or Becker muscular dystrophy: review of 117 anesthetic exposures , 2013, Paediatric anaesthesia.
[2] C. How,et al. Cytochrome P450 drug interactions with statin therapy. , 2013, Singapore medical journal.
[3] C. Mueller,et al. Anaesthetic management in patients with Duchenne muscular dystrophy undergoing orthopaedic surgery: a review of 232 cases , 2012, European journal of anaesthesiology.
[4] C. Cannon,et al. The controversies of statin therapy: weighing the evidence. , 2012, Journal of the American College of Cardiology.
[5] M. Hohenegger. Drug induced rhabdomyolysis , 2012, Current opinion in pharmacology.
[6] K. Kenney,et al. Exertional Rhabdomyolysis: A Clinical Review With a Focus on Genetic Influences , 2012, Journal of clinical neuromuscular disease.
[7] Ş. Eren,et al. Quail consumption can be harmful. , 2011, The Journal of emergency medicine.
[8] S. Czuczwar,et al. Statin-induced myopathies , 2011, Pharmacological reports : PR.
[9] E. Spatz,et al. Statin myopathy: A common dilemma not reflected in clinical trials , 2011, Cleveland Clinic Journal of Medicine.
[10] Z. Abassi,et al. Early fluid resuscitation in patients with rhabdomyolysis , 2011, Nature Reviews Nephrology.
[11] M. Zappitelli,et al. Rhabdomyolysis: pathogenesis of renal injury and management , 2011, Pediatric Nephrology.
[12] T. Kaneko,et al. Peak value of blood myoglobin predicts acute renal failure induced by rhabdomyolysis. , 2010, Journal of critical care.
[13] Lyell K. Jones,et al. Natural history of exertional rhabdomyolysis: A population‐based analysis , 2010, Muscle & nerve.
[14] G. Lippi,et al. Rhabdomyolysis: historical background, clinical, diagnostic and therapeutic features , 2010, Clinical chemistry and laboratory medicine.
[15] R. Reilly,et al. Rhabdomyolysis: a review, with emphasis on the pediatric population , 2010, Pediatric Nephrology.
[16] E. Poch,et al. Rhabdomyolysis and acute kidney injury. , 2009, The New England journal of medicine.
[17] J. Devlin,et al. Incidence of propofol-related infusion syndrome in critically ill adults: a prospective, multicenter study , 2009, Critical care.
[18] R. Hegele,et al. Narrative Review: Statin-Related Myopathy , 2009, Annals of Internal Medicine.
[19] Mythili Seetharaman,et al. Viral Rhabdomyolysis , 2008, Southern medical journal.
[20] A. Alshekhlee,et al. Clinical perspectives of statin-induced rhabdomyolysis. , 2007, The American journal of medicine.
[21] M. Burke,et al. Propofol infusion syndrome , 2006, Forensic science, medicine, and pathology.
[22] R. Mannix,et al. Acute Pediatric Rhabdomyolysis: Causes and Rates of Renal Failure , 2006, Pediatrics.
[23] M. Cziraky,et al. Withdrawn: P68 , 2006 .
[24] John A. Clark,et al. Statin safety: an appraisal from the adverse event reporting system. , 2006, The American journal of cardiology.
[25] Alicja R Rudnicka,et al. Statin safety: a systematic review. , 2006, The American journal of cardiology.
[26] J. Guyton. Benefit versus risk in statin treatment. , 2006, The American journal of cardiology.
[27] H. Bays. Statin safety: an overview and assessment of the data--2005. , 2006, The American journal of cardiology.
[28] Z. Ye,et al. Rhabdomyolysis Following Recent Severe Coxsackie Virus Infection in Patient with Chronic Renal Failure: One Case Report and a Review of the Literature , 2006, Renal failure.
[29] O. Kal,et al. Rhabdomyolysis-induced acute renal failure associated with legionnaires’ disease , 2006, Scandinavian journal of urology and nephrology.
[30] G. Melli,et al. Rhabdomyolysis: An Evaluation of 475 Hospitalized Patients , 2005, Medicine.
[31] A. Mantovani,et al. Circulating levels of the long pentraxin PTX3, an acute phase mediator of innate immunity, in acute lung injury/acute respiratory distress syndrome: functional and prognostic correlations , 2005, Critical Care.
[32] Terry A Jacobson,et al. Comparative pharmacokinetic interaction profiles of pravastatin, simvastatin, and atorvastatin when coadministered with cytochrome P450 inhibitors. , 2004, The American journal of cardiology.
[33] Joseph Varon,et al. Bench-to-bedside review: Rhabdomyolysis – an overview for clinicians , 2004, Critical care.
[34] W. Wong,et al. RHABDOMYOLYSIS TRIGGERED BY CYTOMEGALOVIRUS INFECTION IN A HEART TRANSPLANT PATIENT ON CONCOMITANT CYCLOSPORINE AND ATORVASTATIN THERAPY , 2004, Journal of gastroenterology and hepatology.
[35] D. Packer,et al. Metabolic acidosis associated with propofol in the absence of other causative factors. , 2004, Anesthesiology.
[36] Ronald C. Allison,et al. The Other Medical Causes of Rhabdomyolysis , 2003, The American journal of the medical sciences.
[37] M. Davidson. Combination therapy for dyslipidemia: safety and regulatory considerations. , 2002, The American journal of cardiology.
[38] S. Grundy,et al. ACC/AHA/NHLBI Clinical Advisory on the Use and Safety of Statins. , 2002, Circulation.
[39] J. Warren,et al. Rhabdomyolysis: A review , 2002, Muscle & nerve.
[40] Jennie Chang,et al. Cerivastatin and reports of fatal rhabdomyolysis. , 2002, The New England journal of medicine.
[41] T. Watanabe,et al. Rhabdomyolysis and acute renal failure in children , 2001, Pediatric Nephrology.
[42] I. Hamilton-Craig,et al. Statin‐associated myopathy , 2001, The Medical journal of Australia.
[43] F. Rodríguez,et al. Rabdomiólisis en el curso de un shock tóxico estreptocócico , 2001 .
[44] J. Seiler,et al. Influenza A Induced Rhabdomyolysis Resulting in Extensive Compartment Syndrome , 2000, Clinical orthopaedics and related research.
[45] C. McKay,et al. Ketamine abusers presenting to the emergency department: a case series. , 2000, The Journal of emergency medicine.
[46] F. Apple,et al. Propofol-associated rhabdomyolysis with cardiac involvement in adults: chemical and anatomic findings. , 2000, Clinical chemistry.
[47] M. Rieser,et al. Lack of a Clinically Significant Pharmacokinetic Interaction between Fenofibrate and Pravastatin in Healthy Volunteers , 2000, Journal of clinical pharmacology.
[48] P. Habibi,et al. Short-term propofol infusions in children , 1999, The Lancet.
[49] E. Rondeau,et al. Acute renal failure in the course of HIV infection: a single-institution retrospective study of ninety-two patients and sixty renal biopsies. , 1999, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[50] D. Maclennan,et al. Malignant hyperthermia and central core disease: disorders of Ca2+ release channels. , 1998, The American journal of medicine.
[51] P. Wathen,et al. Primary varicella-zoster-induced rhabdomyolysis. , 1996, Southern medical journal.
[52] S. Paskin,et al. Probable succinylcholine-induced rhabdomyolysis in a male athlete. , 1995, Anesthesia and analgesia.
[53] J. Brook,et al. Rhabdomyolysis complicating acute Epstein-Barr virus infection , 1995, Infection.
[54] R. Wanders,et al. Rhabdomyolysis: a review of the literature , 1993, Clinical Neurology and Neurosurgery.
[55] Wan Ariffin Bin Abdullah. Singapore Med J , 1993 .
[56] A. Knutsen,et al. Rhabdomyolysis and lower extremity compartment syndrome due to influenza B virus. , 1993, Annals of plastic surgery.
[57] D. C. Lewis,et al. Coturnism: Human Poisoning By European Migratory Quail , 1987 .
[58] P. Gabow,et al. The Spectrum of Rhabdomyolysis , 1982, Medicine.
[59] A. Hyman,et al. Myoglobinemia after a single dose of succinylcholine. , 1972, The New England journal of medicine.
[60] H. Giamarellou,et al. Acute renal failure after a meal of quail. , 1971, Lancet.
[61] E. Bywaters,et al. Crush Injuries with Impairment of Renal Function , 1941, British medical journal.
[62] Yiannis S. Chatzizisis,et al. Risk Factors and Drug Interactions Predisposing to Statin-Induced Myopathy Implications for Risk Assessment , Prevention and Treatment , 2012 .
[63] W. Bilker,et al. Clinical importance of the drug interaction between statins and CYP3A4 inhibitors , 2010 .
[64] A. Freire,et al. Rhabdomyolysis in a patient with West Nile encephalitis and flaccid paralysis. , 2008, Tennessee medicine : journal of the Tennessee Medical Association.
[65] T. Lerman-Sagie,et al. Rhabdomyolysis , 2007, Internal and emergency medicine.
[66] M. Davidson,et al. Reporting rate of rhabdomyolysis with fenofibrate + statin versus gemfibrozil + any statin. , 2005, The American journal of cardiology.
[67] D. H.OsamahM.,et al. Rhabdomyolysis complicating acute Epstein-Barr virus infection , 2005, Infection.
[68] H. Bagnulo,et al. [Rhabdomyolysis during a case of streptococcal toxic shock syndrome]. , 2001, Enfermedades infecciosas y microbiologia clinica.
[69] J. Egido. Renal diseases. , 1996, Clinical science.
[70] M. Brezis,et al. Hazard of sauna use after strenuous exercise. , 1994, Annals of internal medicine.
[71] N. Salomon,et al. Special problems in treating tuberculosis. , 1994, Annals of internal medicine.
[72] J. Smialek,et al. Clinical spectrum of accidental hemlock poisoning: neurotoxic manifestations, rhabdomyolysis and acute tubular necrosis. , 1991, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.
[73] L. Kadis,et al. Anesthesia and Uncommon Diseases , 1990 .
[74] H. Gurnaney,et al. Section Editor: Peter J. Davis Malignant Hyperthermia and Muscular Dystrophies , 2022 .